22 February 2022
ASMA Consortium: Improving access to innovative bio therapeutics through acoustic technologies
31 March 2021
Yposkesi welcomes SK Group as new majority equity shareholder, forging solid industrial partnership for growth.
8 December 2020
Yposkesi welcomes Brian Mullan, PhD, as director of innovation, analytical and process development
30 January 2020
Yposkesi’s clinical batches of G1XCGD lentiviral vector used in rare immune system disease study
24 January 2020
